menu
    • menu

    Company profile for Adaptin Bio

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adaptin Bio is a pioneering biotechnology company focused on revolutionizing drug delivery. We develop innovative technologies to enhance how medications and therapeutic compounds reach their target destinations within the body. Our mission is to overcome one of medicine’s biggest challenges: ensuring effective drug delivery to specific tissues. Many critical treatments and diagnostics fail to reach their intended areas, suc...
    Adaptin Bio is a pioneering biotechnology company focused on revolutionizing drug delivery. We develop innovative technologies to enhance how medications and therapeutic compounds reach their target destinations within the body. Our mission is to overcome one of medicine’s biggest challenges: ensuring effective drug delivery to specific tissues. Many critical treatments and diagnostics fail to reach their intended areas, such as the central nervous system, which is protected by the blood-brain barrier. Adaptin Bio aims to overcome these barriers, improving treatment outcomes and patient care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Adaptin BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3540 Toringdon Way Suite 200 Charlotte, NC 28277
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://adaptinbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adaptin Bio Shares to be Quoted on OTCQB Under Ticker Symbol APTN
    Adaptin Bio Shares to be Quoted on OTCQB Under Ticker Symbol APTN

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268508/0/en/Adaptin-Bio-Shares-to-be-Quoted-on-the-OTCQB-Under-Ticker-Symbol-APTN.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Adaptin Bio Progresses Brain Cancer Treatment To Phase 1
    Adaptin Bio Progresses Brain Cancer Treatment To Phase 1

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221935/0/en/Adaptin-Bio-Advances-Novel-Brain-Cancer-Treatment-Candidate-Towards-Phase-1-Glioblastoma-Clinical-Trial.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    Adaptin Bio Presents at 2026 Sequire Summit in Puerto Rico
    Adaptin Bio Presents at 2026 Sequire Summit in Puerto Rico

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219614/0/en/Adaptin-Bio-to-Present-at-the-2026-Sequire-Investor-Summit-in-Puerto-Rico.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    Adaptin Bio Completes $7.7M Private Placement and APO
    Adaptin Bio Completes $7.7M Private Placement and APO

    07 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/07/3057057/0/en/Adaptin-Bio-Inc-a-Lucius-Partners-Portfolio-Company-Completes-Alternative-Public-Offering-APO-and-Closes-7-7-Million-Private-Placement.html

    GLOBENEWSWIRE
    07 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search